SIGNIFICANCE OF FORCED DEGRADATION STUDIES FOR DRUG SUBSTANCE AND DRUG PRODUCTS WITH REFERENCE TO ANTIHYPERTENSIVE AGENTS

Author:

Modi J. G,Patel J. K,Gohel N. A,Modi K. G,Patel K. S.,

Abstract

Stability testing is used to provide evidence of how the quality of an Active Pharmaceutical Ingredient (API) or drug product varies with time under the infuence of a variety of environmental factors such as temperature, humidity and light. If drug product is not stable under various environmental conditions, it may affect the patient safety by formation of a toxic degradation product(s) or deliver a lower dose than expected. Stress testing of the API can help to identify the likely degradation products, which, in turn, can help to establish the degradation pathways and the intrinsic stability of the molecule. Forced degradation study is a process in which the natural degradation rate of a pharmaceutical product is increased by applying an additional stres by which stability of a drug substance or a drug product with effects on purity, potency and safety can be predicted. The present review summarizes the forced degradation study of antihypertensive agents, where degradation products for different stress conditions have been reported. As per review, maximum degradation products have been reported by alkaline, oxidative and photolytic stress conditions.

Publisher

Indian Drug Manufacturers' Association (IDMA)

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference41 articles.

1. 1. Hotha K.K., Reddy S.K., Raju V.K.and Ravindranath L.K.: Forced degradation studies: Practical approach- Overview of regulatory guidance and literature for the drug products and drug substances, Int Research J of Ph, 2013, 4(5), 78-85.

2. 2. World Health Organization, Stability testing of active pharmaceutical ingredients and finished pharmaceutical products, WHO technical report series, 2009, No. 953, 87- 130.

3. 3. Rawat T. and Pandey I.P.: Forced degradation studies for Drug Substances and Drug Products- Scientific and Regulatory Considerations, J Pharm Sci and Research, 2015, 7(5), 238-241.

4. 4. ICH Harmonised Tripartite Guideline Q1A (R2), Stability Testing of New Drug Substances and Products, 2003.

5. 5. ICH Guideline, Stability Testing: Photostability Testing of New Drug Substances and Products, 1996.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3